TB-500 is a synthetic peptide derived from Thymosin Beta-4, a naturally occurring 43-amino-acid protein found in virtually all nucleated mammalian cells. The compound is classified as an actin-sequestering peptide — meaning its primary biochemical role involves binding to G-actin, the globular monomer form of actin, and regulating how actin filaments assemble within cells. Thymosin Beta-4 was first isolated from thymic tissue in the early 1960s, though decades of subsequent research have revealed its expression is far broader than originally understood. TB-500 specifically refers to the active fragment most commonly used in experimental settings, and it attracts significant research interest because of its involvement in cytoskeletal dynamics, cell motility, and intercellular signaling pathways relevant to tissue remodeling studies.
Molecular Structure and Key Properties
TB-500 is a 43-amino-acid peptide with a molecular weight of approximately 4,963 daltons. Its structure includes a central actin-binding domain — a short sequence known as the LKKTET motif — that is responsible for its interaction with G-actin monomers. This motif is highly conserved across species, which makes TB-500 a useful tool in comparative biology research. The peptide is largely unstructured in solution, adopting an extended conformation rather than a tightly folded globular shape. This flexibility is thought to be functionally significant, allowing the peptide to engage actin at multiple points. In laboratory settings, TB-500 is typically supplied as a lyophilized white powder, is water-soluble upon reconstitution, and exhibits reasonable stability under standard cold storage conditions. Researchers should note that, like most peptides of this size, TB-500 is sensitive to repeated freeze-thaw cycling and prolonged exposure to ambient temperatures.
Research Applications
The majority of published TB-500 research examines its role in actin cytoskeleton regulation and cell migration. In vitro studies have used it to investigate how G-actin sequestration affects cell motility, particularly in models involving endothelial cells and keratinocytes. Researchers have measured changes in lamellipodia formation and directional migration in scratch assays and transwell migration platforms following exposure to TB-500. A secondary area of investigation involves its interaction with the transcription factor MRTF-A (myocardin-related transcription factor A), which links actin dynamics to gene expression changes — a pathway with relevance to cardiovascular and fibrotic tissue modeling. Preclinical animal studies, primarily in rodent models, have examined TB-500 in the context of wound healing biology, cardiac tissue remodeling after induced injury, and angiogenesis assays. These studies typically quantify outcomes such as vessel density, cell proliferation markers, and histological tissue architecture rather than functional recovery endpoints. TB-500 has also appeared in research involving stem cell differentiation models, where actin dynamics play a documented role in lineage commitment.
Analytical Use and Sourcing Considerations
Researchers working with TB-500 commonly reconstitute the lyophilized compound in sterile water or dilute acetic acid, depending on the assay requirements. Stocks are typically prepared at concentrations in the nanomolar to low micromolar range for cell-based experiments. Purity is a critical sourcing variable — research-grade TB-500 should be characterized by HPLC with a documented purity of 98% or greater, and mass spectrometry confirmation of the correct molecular weight is standard practice for reputable suppliers. Peptide sequence verification via amino acid analysis or sequencing adds an additional layer of identity confirmation that is particularly important for mechanistic studies where off-target activity could confound results. Researchers should also verify that the compound is manufactured under sterile conditions and is supplied with a certificate of analysis. Endotoxin testing is relevant when TB-500 is used in primary cell culture systems, as bacterial contamination can independently activate inflammatory signaling pathways and compromise experimental validity.
TB-500 remains an active subject of preclinical investigation because its position at the intersection of cytoskeletal biology, transcriptional regulation, and tissue remodeling makes it a versatile probe for understanding fundamental cellular processes. Its well-characterized actin-binding mechanism and cross-species conservation continue to support its utility as a research tool across multiple biological model systems.
For Research Use Only. Not for human consumption. All compounds described in this article are supplied as analytical-grade reagents for institutional in vitro laboratory research only. Not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
